Article
Novel targets in pancreatic cancer research.
Seminars in oncology - 1 Feb 2015
Kozak Geoffrey, Blanco Fernando F, Brody Jonathan R
Abstract excerpt
The initiation and progression of pancreatic ductal adenocarcinoma (PDA) occurs as a result of molecular alterations that typically result in fluctuations of transcription, protein expression, and ultimately dysregulated signaling pathways. For example, PDA is driven by key activating, gain-of-function mutations in proto-oncogenes (eg, K-Ras) along with loss of function of tumor suppressor genes (eg, p16, SMAD4)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
